Dextro-transposition of the great arteries follow up: Difference between revisions
No edit summary |
No edit summary |
||
| Line 30: | Line 30: | ||
==[[ACC AHA Guidelines Classification Scheme]]== | ==[[ACC AHA Guidelines Classification Scheme]]== | ||
}} | }} | ||
==References== | ==References== | ||
<div class="references-small"><references/></div> | <div class="references-small"><references/></div> | ||
Revision as of 17:36, 12 August 2011
|
Dextro-transposition of the great arteries Microchapters |
|
Differentiating dextro-transposition of the great arteries from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Dextro-transposition of the great arteries follow up On the Web |
|
American Roentgen Ray Society Images of Dextro-transposition of the great arteries follow up |
|
Dextro-transposition of the great arteries follow up in the news |
|
Blogs on Dextro-transposition of the great arteries follow up |
|
Risk calculators and risk factors for Dextro-transposition of the great arteries follow up |
|
Transposition of the great vessels Microchapters |
|
Classification |
|---|
|
Differentiating Transposition of the great vessels from other Diseases |
|
Diagnosis |
|
Treatment |
|
Surgery |
|
Case Studies |
|
Dextro-transposition of the great arteries follow up On the Web |
|
American Roentgen Ray Society Images of Dextro-transposition of the great arteries follow up |
|
Dextro-transposition of the great arteries follow up in the news |
|
Blogs on Dextro-transposition of the great arteries follow up |
|
Risk calculators and risk factors for Dextro-transposition of the great arteries follow up |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2]; Cafer Zorkun, M.D., Ph.D. [3]; Keri Shafer, M.D. [4]; Assistant Editor(s)-In-Chief: Kristin Feeney, B.S. [5]
Overview
The American College of Cardiology/American Heart Association (ACC/AHA) recommendations for Endocarditis Prophylaxsis [1](DONOT EDIT)
| “ |
Recommendations for Endocarditis Prophylaxis Class IIa 1. Antibiotic prophylaxis before dental procedures that involve manipulation of gingival tissue or the periapical region of teeth or perforation of the oral mucosa is reasonable in those with the following indications:
2. It is reasonable to consider antibiotic prophylaxis against IE before vaginal delivery at the time of membrane rupture in select patients with the highest risk of adverse outcomes. This includes patients with the following indications:
Class III 1. Prophylaxis against IE is not recommended for nondental procedures (such as esophagogastroduodenoscopy or colonoscopy) in the absence of active infection. (Level of Evidence: C) ACC AHA Guidelines Classification Scheme |
” |
References
- ↑ Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA; et al. (2008). "ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons". J Am Coll Cardiol. 52 (23): e1–121. doi:10.1016/j.jacc.2008.10.001. PMID 19038677.